M
Maryam S. Daneshpour
Researcher at Shahid Beheshti University of Medical Sciences and Health Services
Publications - 164
Citations - 2813
Maryam S. Daneshpour is an academic researcher from Shahid Beheshti University of Medical Sciences and Health Services. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 23, co-authored 142 publications receiving 2131 citations. Previous affiliations of Maryam S. Daneshpour include Tehran University of Medical Sciences & Shahid Beheshti University.
Papers
More filters
Journal ArticleDOI
Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes
Valgerdur Steinthorsdottir,Gudmar Thorleifsson,Patrick Sulem,Hannes Helgason,Niels Grarup,Asgeir Sigurdsson,Hafdis T. Helgadottir,Hrefna Johannsdottir,Olafur Th Magnusson,Sigurjon A. Gudjonsson,Johanne Marie Justesen,Marie Neergaard Harder,Marit E. Jørgensen,Cramer Christensen,Ivan Brandslund,Annelli Sandbæk,Torsten Lauritzen,Henrik Vestergaard,Allan Linneberg,Torben Jørgensen,Torben Jørgensen,Torben Jørgensen,Torben Hansen,Maryam S. Daneshpour,Mohammad-Sadegh Fallah,Astradur B. Hreidarsson,Gunnar Sigurdsson,Fereidoun Azizi,Rafn Benediktsson,Gisli Masson,Agnar Helgason,Augustine Kong,Daniel F. Gudbjartsson,Oluf Pedersen,Unnur Thorsteinsdottir,Kari Stefansson +35 more
TL;DR: Through whole-genome sequencing of 2,630 Icelanders and imputation into 11,114 Icelandic cases and 267,140 controls followed by testing in Danish and Iranian samples, 4 previously unreported variants affecting risk of type 2 diabetes (T2D) are discovered.
Journal ArticleDOI
Point of care testing: The impact of nanotechnology.
Leila Syedmoradi,Maryam S. Daneshpour,Mehrdad Alvandipour,Frank A. Gomez,Hassan Hajghassem,Kobra Omidfar +5 more
TL;DR: Present technologies in on-site or at home POC diagnostic assays implemented in paper-based microfluidic and screen printing devices over the past decade as well as in the near future are discussed.
Journal ArticleDOI
Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease
Anna Helgadottir,Anna Helgadottir,Solveig Gretarsdottir,Gudmar Thorleifsson,Eirikur Hjartarson,Asgeir Sigurdsson,Audur Magnusdottir,Aslaug Jonasdottir,Helgi Kristjansson,Patrick Sulem,Asmundur Oddsson,Gardar Sveinbjornsson,Valgerdur Steinthorsdottir,Thorunn Rafnar,Gisli Masson,Ingileif Jonsdottir,Ingileif Jonsdottir,Isleifur Olafsson,Gudmundur I. Eyjolfsson,Olof Sigurdardottir,Maryam S. Daneshpour,Davood Khalili,Fereidoun Azizi,Dorine W. Swinkels,Lambertus A. Kiemeney,A Quyyumi,Allan I. Levey,Riyaz S. Patel,Salim S. Hayek,Ingibjorg J. Gudmundsdottir,Gudmundur Thorgeirsson,Unnur Thorsteinsdottir,Unnur Thorsteinsdottir,Daniel F. Gudbjartsson,Daniel F. Gudbjartsson,Hilma Holm,Kari Stefansson,Kari Stefansson +37 more
TL;DR: The genetic risk score for non-HDL cholesterol confers CAD risk beyond that of LDL cholesterol (P = 5.5 × 10−8), suggesting that targeting atherogenic remnant cholesterol may reduce cardiovascular risk.
Journal ArticleDOI
Electrochemical sensors and biosensors based on the use of polyaniline and its nanocomposites: a review on recent advances
Nahid Shoaie,Maryam S. Daneshpour,Mostafa Azimzadeh,Sara Mahshid,Seyyed Mehdi Khoshfetrat,Seyyed Mehdi Khoshfetrat,Fatemeh Jahanpeyma,Alieh Gholaminejad,Kobra Omidfar,Kobra Omidfar,Mehdi Foruzandeh +10 more
TL;DR: The simultaneous use of suitable properties polyaniline and nanoparticles can provide the fabrication of sensing systems with high sensitivity, short response time, high signal/noise ratio, low detection limit, and wide linear range by improving conductivity and the large surface area for biomolecules immobilization.
Journal ArticleDOI
Advances in phage display technology for drug discovery.
TL;DR: A widespread application of this methodology is predicted in different medical technological areas, including biosensing, monitoring, molecular imaging, gene therapy, vaccine development and nanotechnology.